This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignees: On-Chip Biotechnologies Co., Ltd., Shizuoka Prefecture. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022
Title: Innovations by Yuri Uehara in Cancer Detection
Introduction
Yuri Uehara is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer detection through his innovative patent. His work focuses on improving the accuracy of cancer metastasis evaluation, which is crucial for effective treatment.
Latest Patents
Uehara holds a patent for an "Apparatus for detecting the degree of malignancy of each of circulating tumor cells." This invention aims to provide an evaluation method capable of accurately determining the metastasis of cancer, the stage of cancer progression, or the malignancy of cancer. The method involves several steps, including the use of fluorescently-labeled components that bind to specific markers on epithelial and mesenchymal cells. By detecting fluorescence or luminescence signals, the degree of epithelial-mesenchymal transition of circulating tumor cells can be determined.
Career Highlights
Throughout his career, Uehara has worked with various organizations, including Shizuoka Prefecture and On-Chip Biotechnologies Co., Ltd. His experience in these companies has contributed to his expertise in the field of biotechnology and cancer research.
Collaborations
Uehara has collaborated with notable individuals in his field, including Namiko Yamashita and Masaru Watanabe. These collaborations have likely enhanced his research and development efforts in cancer detection technologies.
Conclusion
Yuri Uehara's innovative work in cancer detection exemplifies the importance of advancements in medical technology. His patent for detecting malignancy in circulating tumor cells represents a significant step forward in cancer research and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile